Literature DB >> 19951308

Prediction of nucleated cells in bone marrow stem cell products by donor characteristics: a retrospective single centre analysis.

W Bouwmeester1, M M Fechter, M W Heymans, J W R Twisk, L J Ebeling, A Brand.   

Abstract

BACKGROUND AND OBJECTIVES: Number of total nucleated cells is an important prognostic factor of unrelated bone marrow transplantation. The objective of our study was to further optimize donor selection by finding donor characteristics which predict the total nucleated cell concentration in unrelated bone marrow products.
MATERIAL AND METHODS: Data were collected retrospectively from the pre-donation medical records. The outcome variable was concentration of total nucleated cells in the final products. We investigated several candidate predictors, including demographic variables and peripheral blood counts. A backward selection procedure was performed, using multivariable multilevel analysis.
RESULTS: A total of 471 donations were included. Significant predictors were increase of age (ratio per 5 years 0.971), cytomegalovirus (ratio 0.947 if positive), smoking (ratio 1.079 if yes), higher haemoglobin (ratio 1.052 per mmol/l), higher mono-nuclear cells (ratio 1.169 when mono-nuclear cells >2.69 compared to mono-nuclear cells <1.89 x 10E9/l), increasing number of whole blood donations (ratio 1.115 when blood donations >4 compared to blood donation <1), and larger body surface area (ratio 1.179 when body surface area >2.07 compared to body surface area <1.82 m(2)). The model was adjusted for collection volume.
CONCLUSION: Presence of all favourable factors was associated with a twofold higher concentration of total nucleated cells in the bone marrow harvest.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19951308     DOI: 10.1111/j.1423-0410.2009.01281.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

1.  Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.

Authors:  Sandhya R Panch; Brent Logan; Jennifer A Sees; Stephanie Bo-Subait; Bipin Savani; Nirali N Shah; Jack W Hsu; Galen Switzer; Hillard M Lazarus; Paolo Anderlini; Peiman Hematti; Dennis Confer; Michael A Pulsipher; Bronwen E Shaw; David F Stroncek
Journal:  Transplant Cell Ther       Date:  2021-03-09

Review 2.  Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility.

Authors:  Olivier Hequet
Journal:  J Blood Med       Date:  2015-02-18

3.  Index of CD34+ Cells and Mononuclear Cells in the Bone Marrow of Spinal Cord Injury Patients of Different Age Groups: A Comparative Analysis.

Authors:  Vidyasagar Devaprasad Dedeepiya; Yegneswara Yellury Rao; Gosalakkal A Jayakrishnan; Jutty K B C Parthiban; Subramani Baskar; Sadananda Rao Manjunath; Rajappa Senthilkumar; Samuel J K Abraham
Journal:  Bone Marrow Res       Date:  2012-07-05

4.  A dose response analysis of a specific bone marrow concentrate treatment protocol for knee osteoarthritis.

Authors:  Christopher J Centeno; Hasan Al-Sayegh; Jamil Bashir; Shaun Goodyear; Michael D Freeman
Journal:  BMC Musculoskelet Disord       Date:  2015-09-18       Impact factor: 2.362

5.  Structural and Functional Characterization of Deceased Donor Stem Cells: A Viable Alternative to Living Donor Stem Cells.

Authors:  Prakash N Rao; Dayanand D Deo; Misty A Marchioni; Rouzbeh R Taghizadeh; Kyle Cetrulo; Sharyn Sawczak; Jacob Myrick
Journal:  Stem Cells Int       Date:  2019-11-25       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.